Telehealth is rapidly becoming a community expectation Quilty et al Telehealth in remote Northern Territory: bridging the gap TO THE EDITOR: The very real challenges of distance and travel facing people with disabilities in rural and remote Australia were recently highlighted by Samera in this Journal. 1 Here at Katherine Hospital, the barriers to care described by Samera are being overcome through the innovative use of telehealth. For example, a 47-year-old Aboriginal woman was admitted to this hospital after suffering a right-sided intracerebral bleed, leaving her with a dense left-sided hemiplegia and severe cognitive deficits.
To facilitate community placement, the woman needed a wheelchair. Customised wheelchair design is undertaken by the Seating Equipment Assessment and Technical (SEAT) service in Darwin, which visits Katherine only once every 4 months. To overcome this, telehealth appointments were arranged by the SEAT occupational therapist at Royal Darwin Hospital, who remotely guided the occupational therapist at Katherine Hospital through the complex patient assessments that were necessary. As a result, a customised wheelchair was delivered to Katherine Hospital within 6 weeks.
What would previously have taken many months, including two dedicated aeromedical flights to and from Darwin and multiple transfers between hospitals, was all achieved while the patient remained in her room at Katherine Hospital.
Telehealth for Aboriginal patients in remote areas is an ideal model of culturally safe care. It enables a patient to use speciality services in familiar local environments and in the company of their family and trusted health care providers, resulting in greatly improved cultural and language communication and decision making.
Strongyloides infection in pregnancy presents at least a theoretical threat to the mother's health. While chronic Strongyloides infection can be relatively symptom-free, hyperinfection syndrome can ensue in immunocompromised patients, resulting in proliferation of infection, subsequent septicaemia, and a high mortality rate even in the best of circumstances. The administration of systemic steroids is known to be a common iatrogenic cause of the condition. In theory, should a woman require treatment with a steroid in the course of her pregnancy (for example, in the treatment of premature labour), then administering the drug in the presence of Strongyloides infection represents a considerable risk.
A recent report from the United States outlines such a case.
4 A Haitian patient, 25 weeks pregnant and not known to be carrying a worm infection, presented to a New York hospital in premature labour, was administered steroids for the benefit of the fetus, and subsequently developed Strongyloides hyperinfection. The fetus was delivered stillborn, and the mother died of overwhelming sepsis.
S. stercoralis screening is already included in the routine health assessment of some refugee and migrant populations entering Australia, and is employed in well adult checks in some Aboriginal communities. Many unanswered questions remain over the prevalence of the infection in women of childbearing age, the possible effects of infection on the course of a normal pregnancy, and the safety of the principal treatment, ivermectin, during pregnancy.
5 However, given the evidence currently available, we believe that all relevant authorities involved in the antenatal care of women resident in the communities of northern Australia should consider adding S. stercoralis ELISA testing to their routine antenatal and preconception screening. Effective prevention strategies and appropriate treatment approaches will require:
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• improving community-level understanding of ice and its health and social consequences (Box);
• participatory research to better understand the resilience and protective factors that protect particular Indigenous individuals, families and groups from using ice, and to support the recovery of those who do use the drug;
• studies to determine the extent of the problem; and
• epidemiological studies to document current patterns and styles of ATS use, the precise nature of the substance used, and to monitor trends and patterns in the demand for novel substances such as ice among Indigenous Australians.
This will all require not only improved clinical capacity, but a sustained reinvestment in preventive services that have been stimulants (ATS), including ice (Box). In parallel surveys in eight rural and remote communities, with participants recruited opportunistically, 953 community residents provided their views about trends in local drug use. Consistent with the information provided by the interviews, 393 residents (41%) asserted that new drugs were being used in their communities, 106 (11%) nominating ATS as the drugs involved, and 55 (6%) specifically nominating ice. A previous study 2 indicated that no similar reports had appeared in surveys of alcohol, tobacco, cannabis and other substance use during the preceding 15 years in far north Queensland. The same applies to similar settings in Arnhem Land (Northern Territory), where few participants (< 1%) reported that they had ever tried any ATS, and none had used ice. 
